Merck Stock Surges: A Pharma Giant Awakens
Update: 2025-10-01
Description
Pharma stocks surge! Merck leads the charge with an almost eight percent jump after the Trump administration's direct-to-consumer drug sales plan is revealed, boosting investor confidence across the healthcare sector. This rally, combined with positive clinical trial results for Merck's new drug WINREVAIR, marks a significant week for the company, though it's still down nine percent for the year, leaving long-term investors hopeful for a bigger comeback.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
